Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Radiology|May 19, 2025
Incidence rate and malignancy risk in new nodules in a lung cancer screening programmeAndrew W Creamer, Carolyn Horst, Priyam Verghese, et al.
BMJ Open Respiratory Research|February 6, 2025
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening settingAmyn Bhamani, Evangelos Katsampouris, Fanta Bojang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 29, 2025
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Expanded detection of early fibrotic phenotypes using lobar traction bronchiolectasis in lung cancer screeningDaryl O Cheng, Daisuke Yamada, Mehran Azimbagirad, et al.
The Lancet. Public Health|January 28, 2023
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort studyJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Thorax|February 2, 2026
Upstaging of screen-detected lung cancers during diagnostic assessmentMonica L Mullin, Priyam Verghese, Chuen R Khaw, et al.
European Radiology|July 4, 2026
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safeAmyn Bhamani, Chuen R Khaw, Ruth Prendecki, et al.
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Chest|June 30, 2026
Symptom prevalence and impact on lung cancer risk in the SUMMIT studyMonica L Mullin, Andrew W Creamer, Amyn Bhamani, et al.
Pageof 5